摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氟-3-甲基苯酚 | 77772-72-6

中文名称
2-氟-3-甲基苯酚
中文别名
——
英文名称
2-fluoro-3-methylphenol
英文别名
2-fluoro-3-methyl-phenol
2-氟-3-甲基苯酚化学式
CAS
77772-72-6
化学式
C7H7FO
mdl
MFCD09835186
分子量
126.13
InChiKey
QTCQBPOWSWCJLQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    174.2±20.0 °C(Predicted)
  • 密度:
    1.164±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2908199090
  • 包装等级:
    III
  • 危险类别:
    3
  • 危险性防范说明:
    P501,P261,P270,P240,P210,P233,P243,P241,P242,P271,P264,P280,P370+P378,P337+P313,P305+P351+P338,P362+P364,P303+P361+P353,P332+P313,P301+P312+P330,P304+P340+P312,P403+P235
  • 危险品运输编号:
    1993
  • 危险性描述:
    H302+H312+H332,H315,H319,H225

SDS

SDS:7595997f99bcba27ea9e1da0ca1c2dc1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Fluoro-3-methylphenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Fluoro-3-methylphenol
CAS number: 77772-72-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7FO
Molecular weight: 126.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    作为有效 JAK1 抑制剂的嘧啶化合物的优化以及作为临床候选药物的 R507 的发现
    摘要:
    Janus 激酶 (JAK) 在介导免疫反应和细胞生长的 JAK/信号转导器和转录激活剂 (STAT) 信号通路中发挥着关键作用。从高通量筛选 (HTS) 命中到先导化合物优化,一系列嘧啶化合物被发现是有效的 JAK1 抑制剂,其选择性优于 JAK2。基于细胞的测定被用作评估效力和选择性的主要筛选方法,结果通过先导分子的生化和其他细胞测定进一步评估和确认。还讨论了 NADPH 存在下三氟甲基与 CYP3A4 抑制之间的独特相关性,NADPH 的活性随着氟原子的减少而成功降低,IC 50从 0.5 μM 增加至 >10 μM。开发新型且可扩展的氨基苯基中间体合成路线对于发现后期先导分子(包括临床候选药物 R507)至关重要 ( 33 )。在临床前研究中,33通过抑制 IL-2 诱导的 IFNγ 表达在小鼠研究中以及在大鼠胶原诱导的关节炎疾病模型中表现出巨大的功效。
    DOI:
    10.1021/acsmedchemlett.2c00411
  • 作为产物:
    描述:
    6-叔丁基间甲酚三氯化铝乙酰基次氟酸酯 作用下, 以 一氟三氯甲烷甲苯 为溶剂, 反应 5.0h, 生成 2-氟-3-甲基苯酚
    参考文献:
    名称:
    Takemoto, Ichiki; Yamasaki, Kaori, Bioscience, Biotechnology and Biochemistry, 1994, vol. 58, # 3, p. 594 - 595
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
    申请人:——
    公开号:US20020120011A1
    公开(公告)日:2002-08-29
    The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted diamines. A preferred specific N,N-disubstituted diamine is the compound: 1
    这项发明涉及替代多环芳基和杂环芳基的三级杂烷基胺化合物,可用作胆固醇酯转移蛋白(CETP;血浆脂质转移蛋白-I)的抑制剂,以及用于治疗动脉粥样硬化和其他冠状动脉疾病的化合物、组合物和方法。首选的三级杂烷基胺化合物是取代的N,N-二取代二胺。首选的具体N,N-二取代二胺化合物是:1
  • 苯并咪唑或氮杂苯并咪唑-6-羧酸类化合物及其应用
    申请人:广州必贝特医药股份有限公司
    公开号:CN113480534B
    公开(公告)日:2022-05-13
    本发明公开了一种苯并咪唑或氮杂苯并咪唑‑6‑羧酸类化合物及其应用,所述苯并咪唑或氮杂苯并咪唑‑6‑羧酸类化合物具有式(I)所示结构。该苯并咪唑或氮杂苯并咪唑‑6‑羧酸类化合物可以有效激活GLP‑1R下游信号通路,提高cAMP的表达,从而达到促进胰岛素分泌,治疗糖尿病及其并发症的作用,有较大的应用价值。
  • Inhibitors of c-Jun N-terminal kinases
    申请人:Liu Gang
    公开号:US20060173050A1
    公开(公告)日:2006-08-03
    The present invention relates to compounds that are inhibitors of c-jun N-terminal kinase 1, 2, or 3 (JNK1, JNK2, or JNK3), compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the activation of JNK1, JNK2 and JNK3.
    本发明涉及作为c-jun N-末端激酶1、2或3(JNK1、JNK2或JNK3)抑制剂的化合物,包含这些化合物的组合物以及这些化合物在预防或治疗由JNK1、JNK2和JNK3激活调控的疾病中的用途。
  • COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
    申请人:Li Hui
    公开号:US20120028923A1
    公开(公告)日:2012-02-02
    Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.
    披露了公式I的化合物,含有它们的组合物,以及使用这些化合物和组合物治疗调节JAK途径或抑制JAK激酶,特别是JAK2和JAK3,具有治疗用途的条件的方法。还披露了制造这些化合物的方法。
  • PYRROLIDINONE GLUCOKINASE ACTIVATORS
    申请人:Berthel Steven Joseph
    公开号:US20090264445A1
    公开(公告)日:2009-10-22
    Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
    提供的化合物为公式(I): 以及药学上可接受的盐,其中取代基如说明书中所披露。这些化合物以及包含它们的药物组合物,可用于治疗代谢性疾病和障碍,例如,2型糖尿病。
查看更多